Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Systematic Investigation of Iminosugar Click Clusters as Pharmacological Chaperones for the Treatment of Gaucher Disease
Antoine Joosten, Camille Decroocq, Julien de Sousa, et al.
ChemBioChem (2013) Vol. 15, Iss. 2, pp. 309-319
Closed Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

The clinical management of type 2 Gaucher disease
Karin Weiss, Ashley N. Gonzalez, Grisel Lopez, et al.
Molecular Genetics and Metabolism (2014) Vol. 114, Iss. 2, pp. 110-122
Open Access | Times Cited: 106
The Multivalent Effect in Glycosidase Inhibition: A New, Rapidly Emerging Topic in Glycoscience
Philippe Compain, Anne Bodlenner
ChemBioChem (2014) Vol. 15, Iss. 9, pp. 1239-1251
Closed Access | Times Cited: 105
Multivalent Inhibitors for Carbohydrate‐Processing Enzymes: Beyond the “Lock‐and‐Key” Concept
Sébastien G. Gouin
Chemistry - A European Journal (2014) Vol. 20, Iss. 37, pp. 11616-11628
Closed Access | Times Cited: 105
Carbohydrate supramolecular chemistry: beyond the multivalent effect
Manuel González‐Cuesta, Carmen Ortiz Mellet, José M. Garcı́a Fernández
Chemical Communications (2020) Vol. 56, Iss. 39, pp. 5207-5222
Open Access | Times Cited: 85
Tuning protein folding in lysosomal storage diseases: the chemistry behind pharmacological chaperones
David M. Pereira, Patrı́cia Valentão, Paula B. Andrade
Chemical Science (2018) Vol. 9, Iss. 7, pp. 1740-1752
Open Access | Times Cited: 79
Synthesis and biological properties of multivalent iminosugars
Renaud Zelli, Jean‐François Longevial, Pascal Dumy, et al.
New Journal of Chemistry (2015) Vol. 39, Iss. 7, pp. 5050-5074
Closed Access | Times Cited: 72
Multivalent Effect in Glycosidase Inhibition: The End of the Beginning
Philippe Compain
The Chemical Record (2019) Vol. 20, Iss. 1, pp. 10-22
Closed Access | Times Cited: 63
Ambroxol increases glucocerebrosidase (GCase) activity and restores GCase translocation in primary patient-derived macrophages in Gaucher disease and Parkinsonism
Alena E. Kopytova, Georgy N. Rychkov, Михаил Николаев, et al.
Parkinsonism & Related Disorders (2021) Vol. 84, pp. 112-121
Closed Access | Times Cited: 44
Are enzymes sensitive to the multivalent effect? Emerging evidence with glycosidases
Camilla Matassini, Camilla Parmeggiani, Francesca Cardona, et al.
Tetrahedron Letters (2016) Vol. 57, Iss. 49, pp. 5407-5415
Closed Access | Times Cited: 59
Analysis of carbohydrates and glycoconjugates by matrix‐assisted laser desorption/ionization mass spectrometry: An update for 2013–2014
David J. Harvey
Mass Spectrometry Reviews (2018) Vol. 37, Iss. 4, pp. 353-491
Open Access | Times Cited: 56
Nanotechnology in Glycomics: Applications in Diagnostics, Therapy, Imaging, and Separation Processes
Erika Dosekova, Jaroslav Filip, Tomáš Bertók, et al.
Medicinal Research Reviews (2016) Vol. 37, Iss. 3, pp. 514-626
Open Access | Times Cited: 54
Molecular nanoparticle-based gene delivery systems
José L. Jiménez Blanco, Juan M. Benito, Carmen Ortiz Mellet, et al.
Journal of Drug Delivery Science and Technology (2017) Vol. 42, pp. 18-37
Closed Access | Times Cited: 54
Human Acid β‐Glucosidase Inhibition by Carbohydrate Derived Iminosugars: Towards New Pharmacological Chaperones for Gaucher Disease
Camilla Parmeggiani, Serena Catarzi, Camilla Matassini, et al.
ChemBioChem (2015) Vol. 16, Iss. 14, pp. 2054-2064
Open Access | Times Cited: 51
GCase Enhancers: A Potential Therapeutic Option for Gaucher Disease and Other Neurological Disorders
Macarena Martínez‐Bailén, Francesca Clemente, Camilla Matassini, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 823-823
Open Access | Times Cited: 23
Mechanistic Insight into Heptosyltransferase Inhibition by using Kdo Multivalent Glycoclusters
Abdellatif Tikad, Huixiao Fu, Charlotte M. Sevrain, et al.
Chemistry - A European Journal (2016) Vol. 22, Iss. 37, pp. 13147-13155
Closed Access | Times Cited: 41
Synthesis of the first examples of iminosugar clusters based on cyclopeptoid cores
Mathieu L. Lepage, Alessandra Meli, Anne Bodlenner, et al.
Beilstein Journal of Organic Chemistry (2014) Vol. 10, pp. 1406-1412
Open Access | Times Cited: 39
Giant Glycosidase Inhibitors: First‐ and Second‐Generation Fullerodendrimers with a Dense Iminosugar Shell
Jean‐François Nierengarten, Jérémy P. Schneider, Thi Minh Nguyet Trinh, et al.
Chemistry - A European Journal (2017) Vol. 24, Iss. 10, pp. 2483-2492
Closed Access | Times Cited: 37
Synthesis and Therapeutic Applications of Iminosugars in Cystic Fibrosis
Anna Esposito, Daniele D’Alonzo, Maria De Fenza, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3353-3353
Open Access | Times Cited: 28
Multivalent pyrrolidines acting as pharmacological chaperones against Gaucher disease
Marc Borie-Guichot, My Lan Tran, Virginie Garcia, et al.
Bioorganic Chemistry (2024) Vol. 146, pp. 107295-107295
Closed Access | Times Cited: 3
New Directions in Gaucher Disease
Mia Horowitz, Deborah Elstein, Ari Zimran, et al.
Human Mutation (2016) Vol. 37, Iss. 11, pp. 1121-1136
Open Access | Times Cited: 29
Pharmacological Chaperones for the Treatment of α-Mannosidosis
Rocío Rísquez‐Cuadro, Reimi Matsumoto, Fernando Ortega‐Caballero, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 12, pp. 5832-5843
Open Access | Times Cited: 29
Stereoselective Synthesis of C-2 Alkylated Trihydroxypiperidines: Novel Pharmacological Chaperones for Gaucher Disease
Francesca Clemente, Camilla Matassini, Andrea Goti, et al.
ACS Medicinal Chemistry Letters (2019) Vol. 10, Iss. 4, pp. 621-626
Open Access | Times Cited: 26
6-Azido hyacinthacine A2gives a straightforward access to the first multivalent pyrrolizidine architectures
Giampiero D׳Adamio, Camilla Parmeggiani, Andrea Goti, et al.
Organic & Biomolecular Chemistry (2014) Vol. 12, Iss. 32, pp. 6250-6250
Closed Access | Times Cited: 27
Multimerization of DAB-1 onto Au GNPs affords new potent and selective N-acetylgalactosamine-6-sulfatase (GALNS) inhibitors
Camilla Matassini, Costanza Vanni, Andrea Goti, et al.
Organic & Biomolecular Chemistry (2018) Vol. 16, Iss. 44, pp. 8604-8612
Closed Access | Times Cited: 24
Investigation of original multivalent iminosugars as pharmacological chaperones for the treatment of Gaucher disease
Eugénie Laigre, Damien Hazelard, Josefina Casas, et al.
Carbohydrate Research (2016) Vol. 429, pp. 98-104
Closed Access | Times Cited: 23
Page 1 - Next Page

Scroll to top